Wegovy maker Novo Nordisk warns of slower profits as rivals bite
Source: BBC
The Danish-maker of Wegovy and Ozempic has warned that its full-year sales and profits will not grow as quickly as expected as more "knock-off" weight-loss drugs emerge.Novo Nordisk's share price tumbled by more than 20% as it cut its outlook and named a new chief executive to replace Lars Fruergaard Jørgensen, whose surprise exit was announced in May.Maziar Mike Doustdar, currently vice president of Novo…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at BBC